AI & ScienceSep 15, 2026
AI Robot Discovers Hidden Pathway in 130-Year-Old Chemical Reaction
An AI robot uncovered a hidden pathway in the 130-year-old Biginelli reaction, running 1,000 experiments daily to reveal chemistry that humans never.
← Home
AI & Science
213 articles
AI & ScienceSep 14, 2026
Why AI Keeps Confusing Pokémon Characters for Real Drugs
AI drug safety research finds LLMs confuse Pokémon names for real medications up to 99.6% of the time, exposing a dangerous gap in healthcare AI.
AI & ScienceSep 13, 2026
Why AI Drug Discovery Needs Nature's Rulebook, Not Just Algorithms
AI drug discovery gets a reset: a major three-institution collaboration will design biomolecules nature never created, then validate them in living cells.
AI & ScienceSep 12, 2026
Apple's SimpleDesign Skips the Middleman in Protein Design, Challenging AlphaFold's Approach
Apple's SimpleDesign rivals AlphaFold by skipping tokenization entirely, training directly on 2 million protein pairs in one step for faster, simpler.
AI & ScienceSep 11, 2026
From AI Prediction to Factory Floor: How One Startup Is Closing Materials Science's Biggest Gap
Newfound Materials combines physics-driven AI with synthesis expertise to turn materials science predictions into factory-ready products, targeting $250B+.
AI & ScienceSep 11, 2026
How AI Is Reshaping Materials Science Education: A New Vision for the Next Generation
Stevens Institute's new materials science chair is using AI as a problem-solving tool, not a shortcut, to train the next generation of engineers and.
AI & ScienceSep 11, 2026
Former Google Researchers Are Building an AI 'Judge' to Stop Models From Going Rogue
Former Google researchers raised $6.5M to build an AlphaFold-linked AI "judge" that pairs humans with AI to catch rogue model behavior before it escalates.
AI & ScienceSep 11, 2026
How AI Is Learning to Engineer Life's Building Blocks: The Quiet Revolution in Protein Design
Ferris State researchers will show how embedding AI in drug discovery cycles can compress weeks of protein engineering work into days.
AI & ScienceSep 11, 2026
How AI Agents Are Learning to Reason Through Materials Science
The Harness framework keeps AI materials science proposals grounded by validating them against real databases, cutting costly dead ends in materials.
AI & ScienceSep 10, 2026
How NVIDIA's New Protein-Folding Engine Is Speeding Up AlphaFold by Nearly 3x
NVIDIA's BioIR engine accelerates AlphaFold protein-folding nearly 3x, cutting energy use by two-thirds and processing millions of protein complexes at.
AI & ScienceSep 10, 2026
A Free AI Hub Just Mapped 5,846 Rare Diseases to Speed Up Drug Discovery
Explority AI's free hub maps 5,846 rare diseases in one place, cutting weeks of drug discovery research and replacing costly, fragmented tools.
AI & ScienceSep 10, 2026
Two Major AI Breakthroughs Show How Genomics Is Becoming Truly Personalized
AI and genomics are converging fast: a new UC Berkeley model decodes disease-linked DNA in hours, while BGI unveils custom nutrition and biological age.
AI & ScienceSep 10, 2026
South Korea's New Battery Research Platform Cuts Equipment Costs for Startups and Scientists
South Korea's new battery research platform gives scientists and startups access to $44 million in shared lab equipment through a single online portal.
AI & ScienceSep 10, 2026
How AI Is Learning to Read the Hidden Language of Human DNA
UC Berkeley's GPN-Star AI decodes the 98% of human DNA once called "junk," identifying disease-linked genetic variants in hours instead of months.
AI & ScienceSep 9, 2026
Why US Pharma Executives Are Skeptical About AI's Drug-Making Promise
Only 24% of pharma executives expect AI to meaningfully improve drug success rates, even as 72% of companies scale AI across drug discovery.
AI & ScienceSep 9, 2026
Why AI Alone Won't Solve Hydrogen Storage: The Missing Physics Problem
69 researchers say AI hydrogen storage predictions fail without physics constraints, clean data, and experimental feedback loops built in from the start.
AI & ScienceSep 9, 2026
Google DeepMind's New Atlas Maps Every Possible DNA Change,Here's Why That Matters
Google DeepMind's AlphaGenome Atlas maps all nine billion possible DNA mutations, offering free academic access to predictions that could transform rare.
AI & ScienceSep 8, 2026
Pharma's AI Problem: Why Data Integrity and Validation Matter More Than Algorithms
AI drug discovery depends more on data integrity than algorithms, experts warn, as pharma leaders prepare to tackle validation and regulatory gaps this.
AI & ScienceSep 7, 2026
Pharma's AI Revolution Moves Beyond Drug Discovery: How the Industry Is Becoming AI-Native
Pharma's AI revolution is moving beyond drug discovery, with AI-native operations projected to unlock $110 billion in annual global value.
AI & ScienceSep 7, 2026
Liverpool Opens AI-Powered Lab to Speed Up Drug Discovery While Cutting Animal Testing
Liverpool's new £20 million AI-powered drug discovery lab uses robotics and human organoids to speed up treatments while cutting animal testing.
AI & ScienceSep 7, 2026
From Lab Benches to Market Shelves: How Materials Scientists Are Bridging Academia and Industry
AI is shrinking the decades-long gap between materials science labs and market shelves, pushing academics and industry to collaborate from day one.
AI & ScienceSep 5, 2026
Why AI Leaders' Bold Disease-Curing Claims Are Setting Unrealistic Expectations
AI leaders claim curing disease is years away, but experts say 80% of chronic illness stems from lifestyle, not genes that AI can fix.
AI & ScienceSep 4, 2026
Big Pharma's New Competitive Edge: Why Data, Not AI Algorithms, Will Win the Drug Discovery Race
AI drug discovery's real edge isn't algorithms, which are open source; it's rare biological data that competitors can't replicate, industry leaders say.
AI & ScienceSep 4, 2026
NSF Invests $90 Million in 3D Genome Engineering Center to Unlock How DNA Organization Drives Disease
NSF is investing $90 million to study how DNA's 3D folding drives Alzheimer's, cancer, and heart disease, led by Northwestern University's new GENIE.
AI & ScienceSep 4, 2026
How AI Is Cracking the Protein Code Behind Severe Autism
UC San Francisco used AlphaFold AI to map 1,800+ protein interactions in profound autism, potentially replacing gene-by-gene drug development with shared.
AI & ScienceSep 4, 2026
Researchers Create AI System That Learns to Design Better Polymers on Its Own
Tohoku University's new AI system designs better polymers on its own, potentially cutting development time from years to months while slashing waste.
AI & ScienceSep 4, 2026
The Real Challenge With AI-Designed Biology Isn't Creating Super Viruses,It's Building Trust
AI designed 16 viable viruses, but the real biosafety challenge isn't creating super pathogens; it's building governance frameworks fast enough to match.
AI & ScienceSep 4, 2026
AI Is Learning to Predict RNA Structure, Opening New Doors for Gene Therapy and CRISPR
UC Berkeley researchers used AI to crack RNA structure prediction, a breakthrough that could accelerate gene therapy and CRISPR tool development.
AI & ScienceSep 3, 2026
Chemistry Is Forcing AI to Become Smarter. Here's Why That Matters for Science.
Chemistry is forcing AI to become smarter, pushing systems beyond black-box predictions toward transparent, trustworthy models that could transform.
AI & ScienceSep 3, 2026
AI BioDesign: How Scientists Are Learning to Build Life From Scratch
A $95 million initiative is using AI to design entirely new DNA sequences that have never existed in nature, targeting cancer, ocean plastics, and more.
AI & ScienceSep 3, 2026
Oxford and 2U Launch AI Drug Discovery Program as Pharma Embraces Causal AI for Neurological Diseases
Oxford and Ono Pharma are betting on AI drug discovery, with causal AI targeting neurological diseases and a new Oxford program training pharma.
AI & ScienceSep 3, 2026
How AI Drug Discovery Is Becoming a Mainstream Investment: Inside the Market Shift
AI drug discovery is now a mainstream investment, with Insilico Medicine posting 287% revenue growth and $7.3 billion in 2026 partnerships.
AI & ScienceSep 2, 2026
AI Is Reshaping How Doctors Read Your Genome. Here's What's Actually Changing.
AI is reshaping genome analysis by replacing an outdated single reference with a pangenome, helping doctors detect cancer and rare diseases more.
AI & ScienceSep 2, 2026
Three Major Breakthroughs Show AI Drug Discovery Is Moving Beyond Hype Into Real Results
AI drug discovery hit three milestones: causal AI partnerships, a tool screening 69 billion molecules cheaply, and 96% of pharma leaders prioritizing AI.
AI & ScienceSep 2, 2026
AI Just Learned to Build Materials Atom-by-Atom. Here's Why That Changes Everything.
AI can now build materials atom-by-atom without human supervision, assembling a 37-molecule graphene lattice that behaves like the real thing.
AI & ScienceAug 31, 2026
The Rare Disease Diagnostic Odyssey: How AI Is Cutting Through Years of Medical Uncertainty
A $98.5 million federal AI program aims to end the six-year rare disease diagnostic odyssey by building the largest AI-ready rare disease dataset ever.
AI & ScienceAug 31, 2026
AI Just Mapped 14,000 Hidden Microbial Partners. Here's Why That Changes Biology
AI mapped 14,000 hidden symbiotic microbes, revealing 15-23% of uncultivated bacteria live in host partnerships, a find that could unlock new.
AI & ScienceAug 31, 2026
AI Just Screened 150 Million Materials and Found Two Game-Changers for Electronics
AI screened 150 million materials and found two lead-free dielectrics that outperform industry standards for electric vehicles and aerospace electronics.
AI & ScienceAug 31, 2026
Why US Drug Makers Are Scrambling to Decode Europe's AI Rulebook
US pharma companies face a four-layer EU AI rulebook for clinical trials; here's how to build compliant drug discovery pipelines before 2027 deadlines.
AI & ScienceAug 29, 2026
Quantum Computing Meets Materials Science: How Canada and Japan Are Revolutionizing Chip Manufacturing
Xanadu and Mitsubishi Chemical are using quantum simulation to design better semiconductor materials, backed by over $800,000 in Canadian and Japanese.
AI & ScienceAug 29, 2026
AI Is Learning to Read Chemistry Like a Chemist. Here's Why That Changes Everything
AI can now read chemistry like a chemist, helping researchers discover 10 new materials that outperform state-of-the-art water harvesters.
AI & ScienceAug 29, 2026
Scientists Unlock Hidden Gene Circuits in Immune Cells, Opening New Doors for Cancer and Disease Treatment
Scientists mapped nearly 12,800 immune cell genes across 22 million cells, creating a functional rulebook that could transform cancer and autoimmune.
AI & ScienceAug 28, 2026
AI Is Unlocking Wheat's Hidden Genetic Treasure. Here's Why That Matters for Global Food Security
AI is unlocking hidden wheat genetics using k-mers, helping breeders find disease resistance genes faster and protect global food security.
AI & ScienceAug 28, 2026
Why Huawei's Push Into AI Drug Discovery Matters More Than You Think
Huawei is building a domestic AI drug discovery ecosystem using its own chips, but no AI-discovered drug has won approval anywhere in the world yet.
AI & ScienceAug 27, 2026
AI Is Learning to Predict Which Pancreatic Cancer Patients Need Aggressive Treatment
AI can now predict which pancreatic cancer patients need aggressive chemotherapy, with survival jumping from 9.9 to 16 months when matched correctly.
AI & ScienceAug 26, 2026
How AI Is Helping Scientists Save Oysters From Climate Change
Northeastern researchers are using AI to decode oyster DNA, identifying climate-resilient mutations to guide selective breeding and save collapsing oyster.
AI & ScienceAug 26, 2026
Why Pharma Companies Are Moving Away From One-Size-Fits-All AI Solutions
Pharma companies are ditching monolithic AI platforms for modular, task-specific agents that work with existing clinical trial systems without costly.
AI & ScienceAug 26, 2026
Chemistry's New Bottleneck: Why AI Tools Are Fragmenting Instead of Unifying R&D
Chemistry AI is fragmenting R&D instead of unifying it, forcing teams to stitch together tools that can't share data or enable closed-loop learning.
AI & ScienceAug 26, 2026
The AI Drug Discovery Hype Versus Reality: What Northeastern Students Actually Found
Northeastern students found today's AI drug discovery tools make dangerous errors and need constant human oversight, despite a market projected to hit $13.
AI & ScienceAug 26, 2026
Big Tech, Pharma Giants, and AI Startups Are Finally Aligning on Drug Discovery. Here's What Changed.
Pharma giants, AI startups, and Big Tech are dividing drug discovery labor by specialty, accelerating AI-designed candidates into human clinical trials.
Showing 50 of 213 articles